Alamar Biosciences Stock

alamarbio.comHealthcareFounded: 2018Funding to Date: $120.9MM

Alamar biosciences developing medical platforms in the field of proteomics to enable the early detection of cancer and other diseases.

Register for Details

For more details on financing and valuation for Alamar Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Alamar Biosciences.

Register Today

Other companies like Alamar Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 

News

The companies aim to bring together Alamar's immunoassay-based NULISA proteomics platform and Abcam's extensive antibody portfolio.